Radiotherapy-Related Clinical and Functional Sequelae in Lung Cancer Survivors
Metadatos
Mostrar el registro completo del ítemAutor
Heredia Ciuró, Alejandro; Blasco Valls, Paula; Calvache Mateo, Andrés; Valenza Peña, Geraldine; López López, Laura; Ortiz Rubio, Araceli; Valenza, Marie CarmenEditorial
MDPI
Materia
lung cancer radiotherapy physical activity
Fecha
2024-07-05Referencia bibliográfica
Heredia Ciuró, A. et. al. Appl. Sci. 2024, 14, 5874. [https://doi.org/10.3390/app14135874]
Patrocinador
Professional Association of Physiotherapists of Andalusia, Spain (Ilustre Colegio Profesional de Fisioterapeutas de Andalucía) (Award for the Promotion of Oncological Physiotherapy)Resumen
It is known that lung cancer survivors experience sequelae due to the evolution of the
disease and oncological treatment. However, there is no consensus about their sequelae after radiotherapy
treatment. The aim of this study was to analyze the clinical–functional profile of lung cancer
survivors who receive radiotherapy treatment. This prospective observational study evaluated lung
cancer patients who were candidates for radiotherapy treatment in the oncological radiotherapy
unit of San Cecilio University Hospital in Granada. Symptoms (i.e., fatigue, cough, and dyspnea),
functionality (i.e., physical activity levels and muscle mass), and quality of life were evaluated preand
post-radiotherapy treatment. Sixty-five participants were included, and sixty-one completed
both evaluations. Patients showed a significant increase in symptoms (p < 0.05) and a decline in
functionality (p < 0.001) after completing radiotherapy. Quality of life was significantly lower after
completing radiotherapy treatment (p < 0.05). Lung cancer survivors showed an increase in symptoms,
a decline in physical activity levels, and a decline in perceived quality of life after receiving
radiotherapy treatment. These results provide more accurate knowledge about the functional impairment
experienced by lung cancer patients and can facilitate the future management of impairment in
lung cancer patients, thus improving their quality of life.





